New peptide antibiotic stops bacteria by binding where no drug has before
Medicamente
By Dr. Sanchari Sinha Dutta, Ph.D. Mar 27 2025 Lariocidin hits drug-resistant bacteria where others fail — by hijacking the ribosome at a new site, bypassing defences, and opening the door to a new generation of antibiotics. Lariocidin, a lasso-shaped peptide with promising antibiotic properties. (Graphic: Dmitrii Travin and Yury Polikanov). Research: A broad-spectrum lasso peptide antibiotic targeting the bacterial ribosome Researchers at McMaster University, in collaboration with researchers
din zilele anterioare